Literature DB >> 16495543

Endoproteolytic processing of RhoA by Rce1 is required for the cleavage of RhoA by Yersinia enterocolitica outer protein T.

Florian Fueller1, Martin O Bergo, Stephen G Young, Klaus Aktories, Gudula Schmidt.   

Abstract

The bacterial toxin Yersinia outer protein T (YopT) is a cysteine protease that cleaves Rho GTPases immediately upstream of a carboxyl-terminal isoprenylcysteine. By clipping off the lipid anchor, YopT releases Rho GTPases from membranes, resulting in rounding up of mammalian cells in culture. The proteolytic activity of YopT depends on the isoprenylation of the cysteine within the carboxyl-terminal CaaX motif, a reaction carried out by geranylgeranyltransferase type I. The CaaX motif (where "a" indicates aliphatic amino acids) of Rho proteins undergoes two additional processing steps: endoproteolytic removal of the last three amino acids (i.e., -aaX) by Rce1 (Ras-converting enzyme 1) and methylation of the geranylgeranylcysteine by Icmt (isoprenylcysteine carboxyl methyltransferase). In in vitro experiments, RhoA retaining -aaX cannot be cleaved by YopT. Nothing is known, however, about the influence of Rce1-mediated removal of -aaX on the activity of YopT in living cells. We hypothesized that Rce1-deficient mouse fibroblasts, in which the geranylgeranylated Rho proteins are not endoproteolytically processed, would be resistant to YopT. Indeed, this was the case. Microinjection of recombinant YopT into Rce1-deficient fibroblasts had no impact on the subcellular localization of RhoA and no impact on cell morphology. To determine if carboxyl methylation is also required for YopT action, we microinjected YopT into Icmt-deficient fibroblasts. In contrast to the results with Rce1-deficient cells, YopT cleaved RhoA and caused rounding up of the Icmt-deficient cells. Our data demonstrate that Rce1-mediated removal of -aaX from isoprenylated Rho GTPases is required for the proteolytic activity of YopT in living cells, whereas carboxyl methylation by Icmt is not.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495543      PMCID: PMC1418669          DOI: 10.1128/IAI.74.3.1712-1717.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Small GTP-binding proteins.

Authors:  Y Takai; T Sasaki; T Matozaki
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

Review 2.  Rho family proteins: coordinating cell responses.

Authors:  A J Ridley
Journal:  Trends Cell Biol       Date:  2001-12       Impact factor: 20.808

3.  Recombinant Yersinia YopT leads to uncoupling of RhoA-effector interaction.

Authors:  I Sorg; U M Goehring; K Aktories; G Schmidt
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 4.  Rho GTPases in cell biology.

Authors:  Sandrine Etienne-Manneville; Alan Hall
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

5.  Biochemical characterization of the Yersinia YopT protease: cleavage site and recognition elements in Rho GTPases.

Authors:  Feng Shao; Panayiotis O Vacratsis; Zhaoqin Bao; Katherine E Bowers; Carol A Fierke; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

Review 6.  The Yersinia Ysc-Yop 'type III' weaponry.

Authors:  Guy R Cornelis
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

7.  Postprenylation CAAX processing is required for proper localization of Ras but not Rho GTPases.

Authors:  David Michaelson; Wasif Ali; Vi K Chiu; Martin Bergo; Joseph Silletti; Latasha Wright; Stephen G Young; Mark Philips
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

8.  Absence of the CAAX endoprotease Rce1: effects on cell growth and transformation.

Authors:  Martin O Bergo; Patricia Ambroziak; Cria Gregory; Amanda George; James C Otto; Edward Kim; Hiroki Nagase; Patrick J Casey; Allan Balmain; Stephen G Young
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

9.  Hematologic effects of inactivating the Ras processing enzyme Rce1.

Authors:  Abigail L Aiyagari; Brigit R Taylor; Vikas Aurora; Stephen G Young; Kevin M Shannon
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

10.  Isoprenylcysteine carboxyl methyltransferase deficiency in mice.

Authors:  M O Bergo; G K Leung; P Ambroziak; J C Otto; P J Casey; A Q Gomes; M C Seabra; S G Young
Journal:  J Biol Chem       Date:  2000-12-19       Impact factor: 5.157

View more
  6 in total

Review 1.  Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?

Authors:  Adrienne D Cox; Channing J Der; Mark R Philips
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

2.  The polybasic region of Rho GTPases defines the cleavage by Yersinia enterocolitica outer protein T (YopT).

Authors:  Florian Fueller; Gudula Schmidt
Journal:  Protein Sci       Date:  2008-06-26       Impact factor: 6.725

Review 3.  Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.

Authors:  Benjamin Grabowski; M Alexander Schmidt; Christian Rüter
Journal:  Virulence       Date:  2017-03-15       Impact factor: 5.882

4.  The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.

Authors:  Michelle de la Vega; Alyson A Kelvin; Dara J Dunican; Cheryl McFarlane; James F Burrows; Jakub Jaworski; Nigel J Stevenson; Karim Dib; Joshua Z Rappoport; Christopher J Scott; Aideen Long; James A Johnston
Journal:  Nat Commun       Date:  2011-03-29       Impact factor: 14.919

5.  Subversion of actin dynamics by EspM effectors of attaching and effacing bacterial pathogens.

Authors:  Ana Arbeloa; Richard R Bulgin; Georgina MacKenzie; Robert K Shaw; Mark J Pallen; Valerie F Crepin; Cedric N Berger; Gad Frankel
Journal:  Cell Microbiol       Date:  2008-03-05       Impact factor: 3.715

Review 6.  Rce1: mechanism and inhibition.

Authors:  Shahienaz E Hampton; Timothy M Dore; Walter K Schmidt
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-02-09       Impact factor: 8.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.